228 related articles for article (PubMed ID: 20501799)
1. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
[TBL] [Abstract][Full Text] [Related]
2. Clusterin mediates TRAIL resistance in prostate tumor cells.
Sallman DA; Chen X; Zhong B; Gilvary DL; Zhou J; Wei S; Djeu JY
Mol Cancer Ther; 2007 Nov; 6(11):2938-47. PubMed ID: 18025278
[TBL] [Abstract][Full Text] [Related]
3. Secreted clusterin gene silencing enhances chemosensitivity of a549 cells to cisplatin through AKT and ERK1/2 pathways in vitro.
Zhang B; Zhang K; Liu Z; Hao F; Wang M; Li X; Yin Z; Liang H
Cell Physiol Biochem; 2014; 33(4):1162-75. PubMed ID: 24751980
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.
Zhou J; Chen X; Gilvary DL; Tejera MM; Eksioglu EA; Wei S; Djeu JY
Sci Rep; 2015 Oct; 5():15085. PubMed ID: 26469759
[TBL] [Abstract][Full Text] [Related]
5. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
[TBL] [Abstract][Full Text] [Related]
6. Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.
Bouaouiche S; Magadoux L; Dondaine L; Reveneau S; Isambert N; Bettaieb A; Jeannin JF; Laurens V; Plenchette S
Int J Oncol; 2019 Apr; 54(4):1446-1456. PubMed ID: 30720069
[TBL] [Abstract][Full Text] [Related]
7. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
[TBL] [Abstract][Full Text] [Related]
8. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
9. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.
Patterson SG; Wei S; Chen X; Sallman DA; Gilvary DL; Zhong B; Pow-Sang J; Yeatman T; Djeu JY
Oncogene; 2006 Oct; 25(45):6113-22. PubMed ID: 16652143
[TBL] [Abstract][Full Text] [Related]
10. IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin.
Ma X; Bai Y
Mol Med Rep; 2012 Dec; 6(6):1433-7. PubMed ID: 23027041
[TBL] [Abstract][Full Text] [Related]
11. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
Sowery RD; Hadaschik BA; So AI; Zoubeidi A; Fazli L; Hurtado-Coll A; Gleave ME
BJU Int; 2008 Aug; 102(3):389-97. PubMed ID: 18336596
[TBL] [Abstract][Full Text] [Related]
12. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
[TBL] [Abstract][Full Text] [Related]
13. Clusterin and chemoresistance.
Djeu JY; Wei S
Adv Cancer Res; 2009; 105():77-92. PubMed ID: 19879424
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
[TBL] [Abstract][Full Text] [Related]
16. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
Zhang B; Liu ZM; Hao FG; Wang M
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.
Mu L; Yang F; Guo D; Li P; Zhang M
Bioengineered; 2020 Dec; 11(1):472-483. PubMed ID: 32250192
[TBL] [Abstract][Full Text] [Related]
18. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
19. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
Watanabe H; Kawakami A; Sato R; Watanabe K; Matsushita Y; Miyake H
Anticancer Res; 2021 Aug; 41(8):3753-3758. PubMed ID: 34281834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]